SUBCUTANEOUS NODULE

This adverse event was reported 289 times

These drugs are most commonly taken by patients reporting SUBCUTANEOUS NODULE:

# Drug Count
0 ETANERCEPT 38
1 METHOTREXATE SODIUM 23
2 PREDNISONE 23
3 METHOTREXATE 22
4 TERIPARATIDE 22
5 FUROSEMIDE 21
6 CYCLOSPORINE 18
7 MYCOPHENOLATE MOFETIL 17
8 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 17
9 ADALIMUMAB 16
See all common drugs associated with SUBCUTANEOUS NODULE

SUBCUTANEOUS NODULE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMCINONIDE 1 0.0118
1 GADOTERIDOL 8 0.0044
2 GADODIAMIDE 12 0.0036
3 BALSALAZIDE DISODIUM 1 0.0019
4 GADOBENATE DIMEGLUMINE 8 0.0018
5 ACYCLOVIR SODIUM 2 0.0016
6 IBRITUMOMAB TIUXETAN 2 0.0013
7 DACTINOMYCIN 2 0.0009
8 EPOETIN ALFA 8 0.0007
9 MIDODRINE HYDROCHLORIDE 3 0.0007
See all drugs enriched for association with SUBCUTANEOUS NODULE

SUBCUTANEOUS NODULE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Paramagnetic Contrast Agent [EPC] 13 0.0028
1 Antileishmanial [EPC] 1 0.0026
2 Actinomycin [EPC] 2 0.0009
3 Nucleoside Analog Antifungal [EPC] 1 0.0007
4 Calcitonin [EPC] 2 0.0006
5 Skin Test Antigen [EPC] 1 0.0005
6 Lipid-based Polyene Antifungal [EPC] 6 0.0005
7 Provitamin D2 Compound [EPC] 9 0.0003
8 Vitamin D3 Analog [EPC] 6 0.0003
9 Sulfone [EPC] 3 0.0003
See all drug classes enriched for association with SUBCUTANEOUS NODULE